539 related articles for article (PubMed ID: 33382842)
1. Impact of tumor necrosis factor α inhibitors on MRI inflammation in axial spondyloarthritis assessed by Spondyloarthritis Research Consortium Canada score: A meta-analysis.
Huang Y; Chen Y; Liu T; Lin S; Yin G; Xie Q
PLoS One; 2020; 15(12):e0244788. PubMed ID: 33382842
[TBL] [Abstract][Full Text] [Related]
2. Change in MRI in patients with spondyloarthritis treated with anti-TNF agents: systematic review of the literature and meta-analysis.
Khoury G; Combe B; Morel J; Lukas C
Clin Exp Rheumatol; 2021; 39(2):242-252. PubMed ID: 33506749
[TBL] [Abstract][Full Text] [Related]
3. Effects of disease-modifying anti-rheumatic drugs on sacroiliac MRI score in axial spondyloarthritis: a systematic review and meta-analysis.
Hansmaennel A; Fakih O; Gerazime A; Prati C; Chouk M; Wendling D; Verhoeven F
Clin Rheumatol; 2024 Mar; 43(3):1045-1052. PubMed ID: 38158505
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of active inflammation, chronic structural damage, and response to treatment of sacroiliitis in axial spondyloarthritis using the Spondyloarthritis research consortium of Canada scoring system.
Zhang Y; Guo Z; Zhan Y; Qu J; Lei X
BMC Musculoskelet Disord; 2022 Jul; 23(1):654. PubMed ID: 35804360
[TBL] [Abstract][Full Text] [Related]
5. Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial.
van der Heijde D; Baraliakos X; Hermann KA; Landewé RBM; Machado PM; Maksymowych WP; Davies OR; de Peyrecave N; Hoepken B; Bauer L; Nurminen T; Braun J
Ann Rheum Dis; 2018 May; 77(5):699-705. PubMed ID: 29343510
[TBL] [Abstract][Full Text] [Related]
6. Procollagen I N-terminal peptide correlates with inflammation on sacroiliac joint magnetic resonance imaging in ankylosing spondylitis but not in non-radiographic axial spondyloarthritis: A cross-sectional study.
Li X; Liang A; Chen Y; Lam NS; Long X; Xu X; Zhong S
Mod Rheumatol; 2022 Jul; 32(4):770-775. PubMed ID: 34897520
[TBL] [Abstract][Full Text] [Related]
7. Changes over time in inflammatory and structural lesions at the sacroiliac joint in children with spondyloarthritis exposed and unexposed to tumor necrosis factor inhibitor.
Brandon TG; Xiao R; Peterson RG; Chauvin NA; Francavilla ML; Biko DM; Rumsey DG; Stoll ML; Weiss PF
Pediatr Rheumatol Online J; 2021 Dec; 19(1):167. PubMed ID: 34857002
[TBL] [Abstract][Full Text] [Related]
8. Spinal inflammation in the absence of sacroiliac joint inflammation on magnetic resonance imaging in patients with active nonradiographic axial spondyloarthritis.
van der Heijde D; Sieper J; Maksymowych WP; Brown MA; Lambert RG; Rathmann SS; Pangan AL
Arthritis Rheumatol; 2014 Mar; 66(3):667-73. PubMed ID: 24574227
[TBL] [Abstract][Full Text] [Related]
9. Sacroiliac Joint Ankylosis in Young Spondyloarthritis Patients Receiving Biologic Therapy: Observation of Serial Magnetic Resonance Imaging Scans.
Bray TJP; Lopes A; Fisher C; Ciurtin C; Sen D; Hall-Craggs MA
Arthritis Rheumatol; 2019 Apr; 71(4):594-598. PubMed ID: 30295426
[TBL] [Abstract][Full Text] [Related]
10. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).
Sieper J; van der Heijde D; Dougados M; Mease PJ; Maksymowych WP; Brown MA; Arora V; Pangan AL
Ann Rheum Dis; 2013 Jun; 72(6):815-22. PubMed ID: 22772328
[TBL] [Abstract][Full Text] [Related]
12. Treatment With Tumor Necrosis Factor Inhibitors Is Associated With a Time-Shifted Retardation of Radiographic Sacroiliitis Progression in Patients With Axial Spondyloarthritis: 10-Year Results From the German Spondyloarthritis Inception Cohort.
Torgutalp M; Rios Rodriguez V; Proft F; Protopopov M; Verba M; Rademacher J; Haibel H; Sieper J; Rudwaleit M; Poddubnyy D
Arthritis Rheumatol; 2022 Sep; 74(9):1515-1523. PubMed ID: 35437900
[TBL] [Abstract][Full Text] [Related]
13. The Discriminative Values of the Bath Ankylosing Spondylitis Disease Activity Index, Ankylosing Spondylitis Disease Activity Score, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Spondyloarthritis-Related Axial Arthritis.
Tsang HHL; Chung HY
J Clin Rheumatol; 2017 Aug; 23(5):267-272. PubMed ID: 28661926
[TBL] [Abstract][Full Text] [Related]
14. Course of Magnetic Resonance Imaging-Detected Inflammation and Structural Lesions in the Sacroiliac Joints of Patients in the Randomized, Double-Blind, Placebo-Controlled Danish Multicenter Study of Adalimumab in Spondyloarthritis, as Assessed by the Berlin and Spondyloarthritis Research Consortium of Canada Methods.
Pedersen SJ; Poddubnyy D; Sørensen IJ; Loft AG; Hindrup JS; Thamsborg G; Asmussen K; Hendricks O; Nørregaard J; Piil AD; Møller JM; Jurik AG; Balding L; Lambert RG; Sieper J; Østergaard M
Arthritis Rheumatol; 2016 Feb; 68(2):418-29. PubMed ID: 26414004
[TBL] [Abstract][Full Text] [Related]
15. MRI evidence of structural changes in the sacroiliac joints of patients with non-radiographic axial spondyloarthritis even in the absence of MRI inflammation.
Maksymowych WP; Wichuk S; Dougados M; Jones H; Szumski A; Bukowski JF; Marshall L; Lambert RG
Arthritis Res Ther; 2017 Jun; 19(1):126. PubMed ID: 28587658
[TBL] [Abstract][Full Text] [Related]
16. Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP; Wichuk S; Dougados M; Jones HE; Pedersen R; Szumski A; Marshall L; Bukowski JF; Lambert RG
Ann Rheum Dis; 2018 Jan; 77(1):78-84. PubMed ID: 28970212
[TBL] [Abstract][Full Text] [Related]
17. Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long-term open-label adalimumab treatment: 3-year results of the ABILITY-1 trial.
van der Heijde D; Sieper J; Maksymowych WP; Lambert RG; Chen S; Hojnik M; Anderson JK; Pangan AL
Arthritis Res Ther; 2018 Mar; 20(1):61. PubMed ID: 29587851
[TBL] [Abstract][Full Text] [Related]
18. Effects of ixekizumab treatment on structural changes in the sacroiliac joint: MRI assessments at 16 weeks in patients with non-radiographic axial spondyloarthritis.
Maksymowych WP; Baraliakos X; Lambert RG; Landewé R; Sandoval D; Carlier H; Lisse J; Li X; Hojnik M; Østergaard M
Lancet Rheumatol; 2022 Sep; 4(9):e626-e634. PubMed ID: 38288892
[TBL] [Abstract][Full Text] [Related]
19. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
20. Sustained low disease activity measured by ASDAS slow radiographic spinal progression in axial spondyloarthritis patients treated with TNF-inhibitors: data from REGISPONSERBIO.
Llop M; Moreno M; Navarro-Compán V; Juanola X; de Miguel E; Almodóvar R; Quintana EC; Sanz JS; Beltrán E; Montesinos MDR; Calvet J; Berenguer-Llergo A; Gratacós J;
Arthritis Res Ther; 2022 Jan; 24(1):30. PubMed ID: 35063018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]